A rational strategy to support approved COVID-19 vaccines prioritization-Reference-Cited by-同舟云学术

A rational strategy to support approved COVID-19 vaccines prioritization

Published:2021-06-11 Issue:10 Volume:17 Page:3474-3477
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Burgos-Salcedo Javier¹²^ORCID

Affiliation:

1. Biomathematics Department, Corporación para la Investigación y la Innovación-CIINAS, Colombia

2. Centro de investigaciones, Fundación Universitaria San Mateo, Colombia

Funder

no external funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1922060

Reference24 articles.

1. World Health Organization. Coronavirus disease (COVID-19) pandemic. https://covid19.who.int/

2. World Health Organization. Coronavirus disease (COVID-19) pandemic. https://www.covid-19vaccinetracker.org/

3. World Health Organization. Coronavirus disease (COVID-19) pandemic. https://www.who.int/publications/m/item/criteria-for-covid-19-vaccine-prioritization

4. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

5. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What drives the vaccination intention against COVID-19? Application of EPPM, TAM, and theories of risk assessment;Human Vaccines & Immunotherapeutics;2023-01-02

2. Immune network operations in COVID-19;Exploration of Immunology;2022-08-26

3. A qualitative mathematical model of immunocompetence with applications to SARS-CoV-2 immunity;2021-12-13

4. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis;Infectious Diseases of Poverty;2021-11-14